Related references
Note: Only part of the references are listed.Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy
JP Durand et al.
ANTI-CANCER DRUGS (2005)
A randomized phase II study of paclitaxel with carboplatin ± amifostine as first line treatment in advanced ovarian carcinoma
FYFL De Vos et al.
GYNECOLOGIC ONCOLOGY (2005)
A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies
K Hahn et al.
JOURNAL OF NEUROLOGY (2004)
Gabapentin for neuropathic cancer pain: A randomized controlled trial from the gabapentin cancer pain study group
A Caraceni et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Contemporary management of neuropathic pain for the primary care physician
HP Chen et al.
MAYO CLINIC PROCEEDINGS (2004)
Neurologic complications of cancer therapy
SR Plotkin et al.
NEUROLOGIC CLINICS (2003)
Gabapentin in postamputation phantom limb pain: A randomized, double-blind, placebo-controlled, cross-over study
M Bone et al.
REGIONAL ANESTHESIA AND PAIN MEDICINE (2002)
Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: A randomized, double-blind, placebo-controlled trial
S Cascinu et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Chemotherapy-induced peripheral neuropathy
S Quasthoff et al.
JOURNAL OF NEUROLOGY (2002)
Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study
ASC Rice et al.
PAIN (2001)
Gabapentin, an adjuvant treatment for neuropathic pain in a cancer hospital
A Chandler et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2000)